Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 13Genitourinary 11Gastrointestinal 9Breast 9Thoracic 4Sarcoma 4Plasma cell 4Lymphoid 4Head & Neck 4Gynecologic 3Other solid neoplasm 2Myeloid 2Dermatologic 2Classical hematology 1CNS 1

Conditions

Uveal Melanoma 1Melanoma 1

Interventions

Ipilimumab 123pembrolizumab 100Nivolumab 100aldesleukin 89Cyclophosphamide 85fludarabine phosphate 64Interleukin-2 58Dacarbazine 573-ingenyl angelate 42Vemurafenib 39Temozolomide 39Imiquimod 39trametinib 37sargramostim 37Peripheral Blood Stem Cell Transplantation 36incomplete Freund's adjuvant 35dabrafenib 32fludarabine 31Radiotherapy 31Aminolevulinic Acid 30Bevacizumab 29Carboplatin 28Whole-Body Irradiation 25Photochemotherapy 25Paclitaxel 25Filgrastim 25Biopsy 25Interferon-alpha 24Cisplatin 23Sorafenib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Reverse Transcriptase Polymerase Chain Reaction × Dermatologic × Clear all
NCT00004153 2013-09-05

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma

University of Chicago

Phase NA Completed
106 enrolled
Dermatologic

Melanoma

NCT00897624 2011-05-13

Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma

National Cancer Institute (NCI)

Completed
15 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡